Go Pro

Minerva Surgical (UTRS) Competitors

Minerva Surgical logo

UTRS vs. AFIB, SSKN, MOTS, DRTSW, and ANZUW

Should you buy Minerva Surgical stock or one of its competitors? MarketBeat compares Minerva Surgical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Minerva Surgical include Acutus Medical (AFIB), Strata Skin Sciences (SSKN), Motus GI (MOTS), Alpha Tau Medical (DRTSW), and Anzu Special Acquisition Corp I (ANZUW). These companies are all part of the "medical equipment" industry.

How does Minerva Surgical compare to Acutus Medical?

Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Minerva Surgical has higher revenue and earnings than Acutus Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

56.9% of Acutus Medical shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Acutus Medical Neutral

Minerva Surgical has a beta of 2.92, indicating that its stock price is 192% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.67, indicating that its stock price is 467% more volatile than the broader market.

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Minerva Surgical compare to Strata Skin Sciences?

Strata Skin Sciences (NASDAQ:SSKN) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

Strata Skin Sciences has a beta of -0.05, indicating that its stock price is 105% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, indicating that its stock price is 192% more volatile than the broader market.

Minerva Surgical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Minerva Surgical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Strata Skin Sciences-35.64% -476.73% -33.49%
Minerva Surgical N/A N/A N/A

Strata Skin Sciences has higher earnings, but lower revenue than Minerva Surgical. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

In the previous week, Strata Skin Sciences' average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Strata Skin Sciences Neutral
Minerva Surgical Neutral

Given Minerva Surgical's higher probable upside, analysts plainly believe Minerva Surgical is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Minerva Surgical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

32.4% of Strata Skin Sciences shares are held by institutional investors. 40.9% of Strata Skin Sciences shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Minerva Surgical beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

How does Minerva Surgical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Minerva Surgical N/A N/A N/A

Motus GI has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, indicating that its stock price is 192% more volatile than the broader market.

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Minerva Surgical Neutral

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Motus GI has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Minerva Surgical compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Minerva Surgical (NASDAQ:UTRS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Minerva Surgical N/A N/A N/A

Alpha Tau Medical has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

In the previous week, Alpha Tau Medical had 4 more articles in the media than Minerva Surgical. MarketBeat recorded 4 mentions for Alpha Tau Medical and 0 mentions for Minerva Surgical. Alpha Tau Medical's average media sentiment score of 0.40 beat Minerva Surgical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Minerva Surgical Neutral

Summary

Alpha Tau Medical beats Minerva Surgical on 2 of the 3 factors compared between the two stocks.

How does Minerva Surgical compare to Anzu Special Acquisition Corp I?

Minerva Surgical (NASDAQ:UTRS) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

In the previous week, Anzu Special Acquisition Corp I had 1 more articles in the media than Minerva Surgical. MarketBeat recorded 1 mentions for Anzu Special Acquisition Corp I and 0 mentions for Minerva Surgical. Anzu Special Acquisition Corp I's average media sentiment score of 0.87 beat Minerva Surgical's score of 0.00 indicating that Anzu Special Acquisition Corp I is being referred to more favorably in the news media.

Company Overall Sentiment
Minerva Surgical Neutral
Anzu Special Acquisition Corp I Positive

Summary

Anzu Special Acquisition Corp I beats Minerva Surgical on 2 of the 3 factors compared between the two stocks.

Get Minerva Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTRS vs. The Competition

MetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$41.50M$6.87B$12.26B
Dividend YieldN/A1.08%2.67%9.79%
P/E Ratio0.0017.8327.1423.64
Price / SalesN/A28.68517.0688.99
Price / CashN/A18.8650.5459.64
Price / BookN/A8.4910.286.07
Net Income-$34.11M-$16.99M$3.60B$331.99M

Minerva Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340
SSKN
Strata Skin Sciences
N/A$0.00
flat
N/A-99.8%$2K$30.98MN/A120
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$3.76
+0.3%
N/A+1,259.0%$0.00N/AN/A80

Related Companies and Tools


This page (NASDAQ:UTRS) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners